SIA
GSK icon

Sit Investment Associates’s GSK GSK Stock Holding History

Sit Investment Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-54,200
Closed -$3.62M – 441
2014
Q2 		$3.62M Sell
54,200
-680
-1% -$46K 0.06% 242
2014
Q1 		$3.67M Sell
54,880
-9,352
-15% -$632K 0.06% 228
2013
Q4 		$4.29M Sell
64,232
-3,060
-5% -$198K 0.08% 201
2013
Q3 		$4.22M Buy
67,292
+7,312
+12% +$471K 0.08% 198
2013
Q2 		$3.75M Buy
+59,980
New +$3.81M 0.08% 203

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sit Investment Associates's GSK Position: Q3 2014 in Review

Sit Investment Associates sold out of GSK (GSK) in Q3 2014, closing a stake of 54,200 shares — an estimated $3.62M sold.

Sit Investment Associates first reported a position in GSK in Q2 2013 and held it in 5 quarters. The position peaked at $4.29M in Q4 2013. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • Sit Investment Associates reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
  • Sit Investment Associates sold 54,200 GSK shares in Q3 2014, an estimated $3.62M.
  • Sit Investment Associates first reported a position in GSK in Q2 2013 and held it in 5 quarters.
  • Sit Investment Associates's GSK position peaked at $4.29M in Q4 2013.
  • 701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Sit Investment Associates's 13F filing for Q3 2014, filed 27 Oct 2014.